← Holders
MPM Bioimpact LLC
What MPM Bioimpact LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1687078 · Filed Nov 16, 2026
- Positions
- 37
- Reported value
- $1.3B
- Opened
- 37
- Closed
- 37
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$610.9M40 positions
- Dec 31, 2025$874M38 positions
- Mar 31, 2026$1.3B41 positions
- Jun 30, 2026$1.6B37 positions
- Sep 30, 2026$1.3B37 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
CGEMCullinan Therapeutics, Inc. | 9.7M | New | $149.2M | 11.1% |
AKTSAktis Oncology, Inc. | 4.8M | New | $94.2M | 7% |
TVTXTravere Therapeutics, Inc. | 1.1M | New | $64.1M | 4.8% |
EWTXEdgewise Therapeutics, Inc. | 1.6M | New | $64M | 4.7% |
DYNDyne Therapeutics, Inc. | 3.2M | New | $51.7M | 3.8% |
CORTCorcept Therapeutics Inc | 422K | New | $48.6M | 3.6% |
| 422K | New | $48.6M | 3.6% | |
RLAYRelay Therapeutics, Inc. | 2.4M | New | $42.8M | 3.2% |
TRVITrevi Therapeutics, Inc. | 3M | New | $42.7M | 3.2% |
IOVAIovance Biotherapeutics, Inc. | 2.8M | New | $42M | 3.1% |
LQDALiquidia Corp | 1.3M | New | $40.6M | 3% |
NTRANatera, Inc. | 90.6K | New | $37.4M | 2.8% |
URGNUroGen Pharma Ltd. | 909.7K | New | $37M | 2.7% |
IMCRImmunocore Holdings plc | 1.2M | New | $36.4M | 2.7% |
DBVTDBV Technologies S.A. | 3M | New | $35.8M | 2.7% |
TSHATaysha Gene Therapies, Inc. | 7.3M | New | $35.4M | 2.6% |
ABVXAbivax S.A. | 328.4K | New | $32.5M | 2.4% |
VIRVir Biotechnology, Inc. | 2.8M | New | $31.4M | 2.3% |
ANLAdlai Nortye Group Ltd. | 2M | New | $31.3M | 2.3% |
VSTMVerastem, Inc. | 3.9M | New | $31M | 2.3% |
QUREuniQure N.V. | 1.2M | New | $29M | 2.2% |
ODTXOdyssey Therapeutics, Inc. | 1.3M | New | $28.6M | 2.1% |
TARSTarsus Pharmaceuticals, Inc. | 352.7K | New | $27.7M | 2.1% |
PVLAPalvella Therapeutics, Inc. | 197.6K | New | $27.3M | 2% |
ACRSAclaris Therapeutics, Inc. | 5.2M | New | $27.2M | 2% |
ORKAOruka Therapeutics, Inc. | 300K | New | $25M | 1.9% |
ORICOric Pharmaceuticals, Inc. | 1.8M | New | $24.5M | 1.8% |
STOKStoke Therapeutics, Inc. | 925.1K | New | $24.1M | 1.8% |
BLTEBelite Bio, Inc | 133.4K | New | $22.7M | 1.7% |
NGNENeurogene Inc. | 771.8K | New | $21.5M | 1.6% |
ZURAZura Bio Ltd | 4.4M | New | $18.5M | 1.4% |
ANNXAnnexon, Inc. | 4.3M | New | $18.1M | 1.3% |
GLUEMonte Rosa Therapeutics, Inc. | 1.1M | New | $13.4M | 1% |
BIOABioAge Labs, Inc. | 1.9M | New | $13.2M | 1% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 1.7M | New | $11.4M | 0.8% |
DRUGBright Minds Biosciences Inc. | 195.7K | New | $9.7M | 0.7% |
TRAXFirst Tracks Biotherapeutics, Inc. | 254.4K | New | $9M | 0.7% |